Hypertension, obesity, and coronary artery disease in the survivors of congenital heart disease

Canadian Journal of Cardiology

Volumn 29, Issue 7, 2013, Pages 841-848

  Roche, S Lucy ^a,b   Silversides, Candice K ^a,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BODY MASS; BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COGNITIVE DEFECT; COMORBIDITY; CONGENITAL HEART DISEASE; CORONARY ARTERY DISEASE; DEMENTIA; DIASTOLIC BLOOD PRESSURE; EXERCISE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE MASS; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HUMAN; HYPERTENSION; INTRAVASCULAR ULTRASOUND; KIDNEY FAILURE; MORBIDITY; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PULMONARY VALVE ATRESIA; REVIEW; SLEEP DISORDERED BREATHING; SYSTOLIC BLOOD PRESSURE; TRICUSPID VALVE REGURGITATION; TURNER SYNDROME;

CORONARY ARTERY DISEASE; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION; OBESITY; PREVALENCE; RISK FACTORS; SURVIVORS;

EID: 84879498188     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.03.021     Document Type: Review

References (96)

1. Silversides C.K., Marelli A., Beauchesne L., et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: executive summary. Can J Cardiol 2010, 26:143-150.
2. Afilalo J., Therrien J., Pilote L., et al. Geriatric congenital heart disease. JAm Coll Cardiol 2011, 58:1509-1515.
3. Kannel W.B., Wolf P.A., Verter J., McNamara P.M. Epidemiologic assessment of the role of blood pressure in stroke: the Framingham Study. 1970. JAMA 1996, 276:1269-1278.
4. Nagai M., Hoshide S., Kario K. Hypertension and dementia. Am J Hypertens 2009, 23:116-124.
5. Griffin K.A., Bidani A. Hypertension and kidney damage. JClin Hypertens (Greenwich) 2006, 8:209-214.
6. Moons P., Deyk K.V., Dedroog D., Troost E., Budts W. Prevalence of cardiovascular risk factors in adults with congenital heart disease. Eur J Cardiovasc Prev Rehabil 2006, 13:612-616.
7. Verheugt C.L., Uiterwaal C.S., van der Velde E.T., et al. Mortality in adult congenital heart disease. Eur Heart J 2010, 31:1220-1229.
8. Tzemos N., Therrien J., Yip J., Thanassoulis G., et al. Outcomes in adults with bicuspid aortic valves. JAMA 2008, 300:1317-1325.
9. Thanassoulis G., Yip J.W., Filion K., et al. Retrospective study to identify predictors of the presence and rapid progression of aortic dilatation in patients with bicuspid aortic valves. Nat Clin Pract Cardiovasc Med 2008, 5:821-828.
10. Redington A. The physiology of the Fontan circulation. Prog Pediatr Cardiol 2006, 22:179-186.
11. Cohen M., Fuster V., Steele P.M., Driscoll D., McGoon D.C. Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction. Circulation 1989, 80:840-845.
12. Toro-Salazar O.H., Steinberger J., Thomas W., Rocchini A.P., Carpenter B., Moller J.H. Long-term follow-up of patients after coarctation of the aorta repair. Am J Cardiol 2002, 89:541-547.
13. Heger M., Willfort A., Neunteufl T., et al. Vascular dysfunction after coarctation repair is related to the age at surgery. Int J Cardiol 2005, 99:295-299.
14. O'Sullivan J.J., Derrick G., Darnell R. Prevalence of hypertension in children after early repair of coarctation of the aorta: a cohort study using casual and 24-hour blood pressure measurement. Heart 2002, 88:163-166.
15. Hager A., Kanz S., Kaemmerer H., Schreiber C., Hess J. Coarctation Long-term Assessment (COALA): significance of arterial hypertension in a cohort of 404 patients up to 27 years after surgical repair of isolated coarctation of the aorta, even in the absence of restenosis and prosthetic material. JThorac Cardiovasc Surg 2007, 134:738-745.
16. Holzer R., Qureshi S., Ghasemi A., Vincent J., et al. Stenting of aortic coarctation: acute, intermediate, and long-term results of a prospective multi-institutional registry-Congenital Cardiovascular Interventional Study Consortium (CCISC). Catheter Cardiovasc Interv 2010, 76:553-563.
17. Sybert V.P. Cardiovascular malformations and complications in Turner syndrome. Pediatrics 1998, 101:E11.
18. Giordano R., Forno D., Lanfranco F., Manieri C., Ghizzoni L., Ghigo E. Metabolic and cardiovascular outcomes in a group of adult patients with Turner's syndrome under hormonal replacement therapy. Eur J Endocrinol 2011, 164:819-826.
19. Nathwani N.C., Unwin R., Brook C.G., Hindmarsh P.C. Blood pressure and Turner syndrome. Clin Endocrinol (Oxf) 2000, 52:363-370.
20. Gravholt C.H., Hansen K.W., Erlandsen M., Ebbehøj E., Christiansen J.S. Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome. JHypertens 2006, 24:353-360.
21. Elsheikh M., Casadei B., Conway G.S., Wass J.A. Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome. Clin Endocrinol (Oxf) 2001, 54:69-73.
22. Bondy C.A. Aortic dissection in Turner syndrome. Curr Opin Cardiol 2008, 23:519-526.
23. Bodri D. Oocyte donation in patients with Turner's syndrome: a successful technique but with an accompanying high risk of hypertensive disorders during pregnancy. Hum Reprod 2005, 21:829-832.
24. Practice Committee of the American Society for Reproductive Medicine Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil Steril 2012, 97:282-284.
25. Daskalopoulou S.S., Khan N.A., Quinn R.R., et al. The 2012 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2012, 28:270-287.
26. Urbina E., Alpert B., Flynn J., et al. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension 2008, 52:433-451.
27. Lurbe E., Cifkova R., Cruickshank J.K., et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. JHypertens 2009, 27:1719-1742.
28. Warnes C.A., Williams R.G., Bashore T.M., et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease. JAm Coll Cardiol 2008, 52:e143-e263.
29. Baumgartner H., Bonhoeffer P., De Groot N.M., et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010, 31:2915-2957.
30. Public Health Agency of Canada. Obesity in Canada: A joint report from the Public Health Agency of Canada and the Canadian Institute for Health Information. 2011:1-62.
31. Roberts K.C., Shields M., de Groh M., Aziz A., Gilbert J.A. Overweight and obesity in children and adolescents: results from the 2009 to 2011 Canadian Health Measures Survey. Health Rep 2012, 23:37-41.
32. Zomer A.C., Vaartjes I., Uiterwaal C.S.P., et al. Social burden and lifestyle in adults with congenital heart disease. Am J Cardiol 2012, 109:1657-1663.
33. Medoff-Cooper B., Naim M., Torowicz D., Mott A. Feeding, growth, and nutrition in children with congenitally malformed hearts. Cardiol Young 2010, 20:149-153.
34. Peterson R.E., Wetzel G.T. Growth failure in congenital heart disease: where are we now?. Curr Opin Cardiol 2004, 19:81-83.
35. Ono M., Boethig D., Goerler H., Lange M., Westhoff-Bleck M., Breymann T. Somatic development long after the Fontan operation: factors influencing catch-up growth. JThorac Cardiovasc Surg 2007, 134:1199-1206.
36. Carmona F., Hatanaka L.S., Barbieri M.A., et al. Catch-up growth in children after repair of Tetralogy of Fallot. Cardiol Young 2012, 22:507-513.
37. Vaidyanathan B., Radhakrishnan R., Sarala D.A., Sundaram K.R., Kumar R.K. What determines nutritional recovery in malnourished children after correction of congenital heart defects?. Pediatrics 2009, 124:e294-e299.
38. Vogt K.N., Manlhiot C., Van Arsdell G., et al. Somatic growth in children with single ventricle physiology. JAm Coll Cardiol 2007, 50:1876-1883.
39. Jackson M., Poskitt E.M. The effects of high-energy feeding on energy balance and growth in infants with congenital heart disease and failure to thrive. Br J Nutr 2007, 65:131-143.
40. Schwarz S.M., Gewitz M.H., See C.C., et al. Enteral nutrition in infants with congenital heart disease and growth failure. Pediatrics 1990, 86:368-373.
41. Shustak R.J., McGuire S.B., October T.W., Phoon C.K.L., Chun A.J.L. Prevalence of obesity among patients with congenital and acquired heart disease. Pediatr Cardiol 2011, 33:8-14.
42. Pinto N.M., Marino B.S., Wernovsky G., et al. Obesity is a common comorbidity in children with congenital and acquired heart disease. Pediatrics 2007, 120:e1157-e1164.
43. Chung S.T., Hong B.J., Patterson L.W., Petit C., Ham J.Y. High overweight and obesity rates in Fontan patients: a twenty year history [abstract]. Circulation 2012, 126:A18917.
44. Cohen M.S., Zak V., Atz A.M., et al. Anthropometric measures after Fontan procedure: implications for suboptimal functional outcome. Am Heart J 2010, 160:1092-1098. 1098.e1.
45. Stefan M.A., Hopman W.M., Smythe J.F. Effect of activity restriction owing to heart disease on obesity. Arch Pediatr Adolesc Med 2005, 159:477-481.
46. Dua J.S., Cooper A.R., Fox K.R., Stuart A.G. Physical activity levels in adults with congenital heart disease. Eur J Cardiovasc Prev Rehabil 2007, 14:287-293.
47. Lunt D., Briffa T., Briffa N.K., Ramsay J. Physical activity levels of adolescents with congenital heart disease. Aust J Physiother 2003, 49:43-50.
48. Pemberton V.L., McCrindle B.W., Barkin S., et al. Report of the National Heart, Lung, and Blood Institute's Working Group on obesity and other cardiovascular risk factors in congenital heart disease. Circulation 2010, 121:1153-1159.
49. Graham T.P., Driscoll D.J., Gersony W.M., et al. Task Force 2: congenital heart disease. JAm Coll Cardiol 2005, 45:1326-1333.
50. Maron B.J., Chaitman B.R., Ackerman M.J., et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 2004, 109:2807-2816.
51. Resnick H.E., Valsania P., Halter J.B., Lin X. Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults. JEpidemiol Community Health 2000, 54:596-602.
52. Eckel R.H. Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1997, 96:3248-3250.
53. Schwartz A.R., Patil S.P., Laffan A.M., Polotsky V., Schneider H., Smith P.L. Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc 2008, 5:185-192.
54. Daniels S.R. Complications of obesity in children and adolescents. Int J Obes (Lond) 2009, 33:S60-S65.
55. Pasquali S.K., Marino B.S., Powell D.J., et al. Following the arterial switch operation, obese children have risk factors for early cardiovascular disease. Congenit Heart Dis 2010, 5:16-24.
56. Yetman A.T., McCrindle B.W. The prevalence and clinical impact of obesity in adults with Marfan syndrome. Can J Cardiol 2010, 26:137-139.
57. Zaidi A.N., Bauer J.A., Michalsky M.P., et al. The impact of obesity on early postoperative outcomes in adults with congenital heart disease. Congenit Heart Dis 2011, 6:241-246.
58. Holst K.A., Dearani J.A., Burkhart H.M., et al. Risk factors and early outcomes of multiple reoperations in adults with congenital heart disease. Ann Thorac Surg 2011, 92:122-130.
59. Macha M., Molina E.J., Franco M., et al. Pre-transplant obesity in heart transplantation: are there predictors of worse outcomes?. Scand Cardiovasc J 2009, 43:304-310.
60. Patarroyo M., Simbaqueba C., Shrestha K., et al. Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era. JHeart Lung Transplant 2012, 31:282-287.
61. Grady K.L., White-Williams C., Naftel D., et al. Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: a multi-institutional study of preoperative weight-height indices. Cardiac Transplant Research Database (CTRD) Group. JHeart Lung Transplant 1999, 18:750-763.
62. Kaufman B.D., Shaddy R.E., Shirali G.S., Tanel R., Towbin J.A. Assessment and management of the failing heart in children. Cardiol Young 2008, 18(suppl 3):63-71.
63. Rossano J.W., Grenier M.A., Dreyer W.J., et al. Effect of body mass index on outcome in pediatric heart transplant patients. JHeart Lung Transplant 2007, 26:718-723.
64. Lau D.C., Douketis J.D., Morrison K.M., et al. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ 2007, 176:S1-13.
65. Rao G., Burke L.E., Spring B.J., et al. New and emerging weight management strategies for busy ambulatory settings: a scientific statement from the American Heart Association endorsed by the Society of Behavioral Medicine. Circulation 2011, 124:1182-1203.
66. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association [erratum in 2012;125:e1002]. Circulation 2012, 125:e2-220.
67. Lloyd-Jones D.M., Larson M.G., Leip E.P., et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002, 106:3068-3072.
68. Opotowsky A.R., Siddiqi O.K., Webb G.D. Trends in hospitalizations for adults with congenital heart disease in the U.S. JAm Coll Cardiol 2009, 54:460-467.
69. Yalonetsky S., Horlick E.M., Osten M.D., Benson L.N., Oechslin E.N., Silversides C.K. Clinical characteristics of coronary artery disease in adults with congenital heart defects. Int J Cardiol 2013, 164:217-220.
70. Giannakoulas G., Dimopoulos K., Engel R., et al. Burden of coronary artery disease in adults with congenital heart disease and its relation to congenital and traditional heart risk factors. Am J Cardiol 2009, 103:1445-1450.
71. Freedom R.M., Anderson R.H., Perrin D. The significance of ventriculo-coronary arterial connections in the setting of pulmonary atresia with an intact ventricular septum. Cardiol Young 2005, 15:447-468.
72. Mawson J.B. Congenital heart defects and coronary anatomy. Tex Heart Inst J 2002, 29:279-289.
73. Massoudy P. Anatomic variability in coronary arterial distribution with regard to the arterial switch procedure. Circulation 2002, 106:1980-1984.
74. Legendre A., Losay J., Touchot-Koné A., et al. Coronary events after arterial switch operation for transposition of the great arteries. Circulation 2003, 108(suppl 1):II186-II190.
75. Pedra S.R., Pedra C.A., Abizaid A.A., et al. Intracoronary ultrasound assessment late after the arterial switch operation for transposition of the great arteries. JAm Coll Cardiol 2005, 45:2061-2068.
76. Tobler D., Williams W.G., Jegatheeswaran A., et al. Cardiac outcomes in young adult survivors of the arterial switch operation for transposition of the great arteries. JAm Coll Cardiol 2010, 56:58-64.
77. Marsalese D.L., Moodie D.S., Vacante M., et al. Marfan's syndrome: natural history and long-term follow-up of cardiovascular involvement. JAm Coll Cardiol 1989, 14:422-428. [discussion: 429-31].
78. Gravholt C.H., Juul S., Naeraa R.W., Hansen J. Morbidity in Turner syndrome. JClin Epidemiol 1998, 51:147-158.
79. Garden A.S., Diver M.J., Fraser W.D. Undiagnosed morbidity in adult women with Turner's syndrome. Clin Endocrinol (Oxf) 1996, 45:589-593.
80. Aligeti V.R., Horn H.R. Turner's syndrome and coronary artery disease. Am J Cardiol 2007, 99:741-742.
81. Kozlowska-Wojciechowska M., Jez W., Zdrojewski T., Chwojnicki K. Are young women with Turner syndrome at greater risk of coronary artery disease?. Eur J Cardiovasc Prev Rehabil 2006, 13:467-469.
82. Maron B.J., Humphries J.O., Rowe R.D., Mellits E.D. Prognosis of surgically corrected coarctation of the aorta. A 20-year postoperative appraisal. Circulation 1973, 47:119-126.
83. Roifman I., Therrien J., Ionescu-Ittu R., et al. Coarctation of the aorta and coronary artery disease: fact or fiction?. Circulation 2012, 126:16-21.
84. Brili S., Tousoulis D., Antoniades C., et al. Evidence of vascular dysfunction in young patients with successfully repaired coarctation of aorta. Atherosclerosis 2005, 182:97-103.
85. Sarkola T., Redington A.N., Slorach C., Hui W., Bradley T., Jaeggi E. Assessment of vascular phenotype using a novel very-high-resolution ultrasound technique in adolescents after aortic coarctation repair and/or stent implantation: relationship to central haemodynamics and left ventricular mass. Heart 2011, 97:1788-1793.
86. Barker D.J. Fetal origins of coronary heart disease. BMJ 1995, 311:171-174.
87. Berenson G.S., Srinivasan S.R., Bao W., et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. NEngl J Med 1998, 338:1650-1656.
88. Tuzcu E.M., Kapadia S.R., Tutar E., et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation 2001, 103:2705-2710.
89. Guerri-Guttenberg R.A., Castilla R., Francos G.C., Müller A., Ambrosio G., Milei J. Transforming growth factor β1 and coronary intimal hyperplasia in pediatric patients with congenital heart disease. Can J Cardiol 2013, 29:849-857.
90. Kavey R.E., Allada V., Daniels S.R., et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation 2006, 114:2710-2738.
91. Perk J., De Backer G., Gohlke H., et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2012, 33:1635-1701.
92. Greenland P., Alpert J.S., Beller G.A., et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2010, 122:e584-e636.
93. Fletcher B. Managing abnormal blood lipids: a collaborative approach. Circulation 2005, 112:3184-3209.
94. Canadian Cardiovascular Society 1998 Consensus Conference on the Prevention of Cardiovascular Diseases: the role of the cardiovascular specialist. Can J Cardiol 1999, 15(suppl G):1G-119G.
95. Nguyen T., Lau D.C. The obesity epidemic and its impact on hypertension. Can J Cardiol 2012, 28:326-333.
96. Marelli A.J., Mackie A.S., Ionescu-Ittu R., Rahme E., Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 2006, 115:163-172.